IL-34 and Immune Checkpoint Inhibitors Resistant through Macrophages: Pan-Cancer Overview

Abstract

Mohammed Safi,1,* Al-shaebi Fadhl,1,* Yousif A Algabri,2 Caiqing Zhang1 1Department of Respiratory Diseases, Shandong Second Provincial General Hospital, Shandong University, Jinan, Shandong, People’s Republic of China; 2Department of Biomedical Engineering, School of Control Science and Engineering, Shandong University, Jinan, Shandong, People’s Republic of China*These authors contributed equally to this workCorrespondence: Caiqing Zhang, Department of respiratory, Shandong Second Provincial General Hospital, Shandong University, Jinan, Shandong, 250023, People’s Republic of China, Email [email protected] Al-shaebi Fadhl, Email [email protected]